Clinical observation on HLF regimen in the treatment of 126 cases of malignant tumor of digestive tract
SUN Hui-juan , QIN Feng-zhan , ZHENG Rong-sheng ,et al. Department of Medical Oncology, Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China .
Objective To observe the clinical efficacy and toxicity of the combination chemotherapy with hydroxycamptothecin(HCPT), leucovorin(CF) and 5-fluorouracil(5-FU) in the treatment of malignant tumor of digestive tract. Methods One hundred and twenty-six patients with malignant tumor of digestive tract were treated with HLF regimen. HCPT was given on the days 1-5 at a dose of 10mg/m~2, CF was given on the days 1-5 at a dose of 100mg/m~2 and 5-FU was given on the days 1-5 at a dose of 500mg/m~2 by intravenous drip each day. The chemotherapy was repeated every 21 days and a course of treatment included 2~4 cycles. Results 3 patients showed complete response, 33 partial response, the total effective rate was 33.3%, the effective rate of colorectal cancer was 47.3%, carcinoma of stomach was 35.5%, liver cancer was 10.0%, carcinoma of esophagus was 30.0%, carcinoma of cholecyst was 22.2%. The main toxic effects were nausea, vomiting and myelosuppression, more of them were grade Ⅰ~Ⅱ. Conclusion HLF regimen is effective and safe for advanced digestive tract cancer, the toxic effects are mild.
【CateGory Index】： R735